Nav Button - Home

This issue...

  News in Brief

  SciDAC

  Earliest Hominid Discovery

  New Lens Helps Find Cancer Tumors

  Are the Digits of Pi Random?

  Doubly Strange Nuclei

  People

  About

  Subscribe Free



































This issue...

  News in Brief

  SciDAC

  Earliest Hominid Discovery

  New Lens Helps Find Cancer Tumors

  Are the Digits of Pi Random?

  Doubly Strange Nuclei

  People

  About

  Subscribe Free

New Lens Could Help Find Cancer Tumors Earlier

by Catherine Foster

A new approach to cancer detection is being developed at the U.S. Department of Energy's Argonne National Laboratory. Using a copper crystal lens, researchers expect to find tumors no larger than a grain of rice.

gamma ray lens and phantom
Argonne scientist Bob Smither invented a gamma-ray lens so precise that it could help detect tumors as small as a grain of rice. (Argonne National Laboratory photo by George Joch)]

The new lens technology, developed by scientists at Argonne's Advanced Photon Source, uses gamma rays diffracted by a set of 828 copper crystal cubes arranged in 13 concentric rings in a disk slightly smaller than a dinner plate. The lens focuses the gamma radiation emitted from a small radioactive source in the body of a patient into a small, well-shielded detector.

This application is simulated by placing a small radioactive source in a "phantom"—an acrylic plastic device designed to simulate areas of the human body—and scanning the phantom with the lens system. The technology can pick up mildly radioactive tracers as small as a dill seed.

"The key is sensitivity and special resolution," says developer Bob Smither. In addition to picking up the smaller sized tumor, the technology can also pinpoint its location within a millimeter or two.

Most cancers are presently found with gamma cameras, which provide images of potential tumors in the body by detecting the radiation emitted by a radiopharmaceutical given to a patient undergoing a full-body scan.

Suspected tumor regions collect higher concentrations of the radiopharmaceutical, which produces a higher count rate and therefore a detectable contrast between the tumor region and its surroundings.

The Argonne-developed lens is designed to supplement full-body scans done with a gamma camera. The gamma lens could be used following the full-body scan to reveal additional detail about suspect areas found during the scan, which means no additional radiopharmaceutical would be needed.

The device, set up as a six-lens array, will detect tumors as small as two millimeters in diameter, Smither said. "Moreover, it can provide sufficient information to determine the location of a tumor accurately in three dimensions, and thereby eliminate the uncertainties in the full-body scan," he added.

Smither estimates the cost of the instrumentation to be less than $100,000, making it affordable to medical facilities of all sizes.

In addition, Smither also sees great potential for the gamma lens in a two-lens array as a possible replacement for mammography, because of its ability to locate very small tumors without discomfort to the patient. A full-scale medical imaging lens was constructed and tested with a number of phantoms in Smither's research laboratory.

The researchers will next design and build a smaller lens to see if the resolution can be improved even more, continuing experiments with phantoms. They expect to test the array in clinical trials in two or three years.

Smither built the world's first gamma-ray lens-a 20-inch lens for use in an astrophysics telescope—10 years ago at Argonne. He also has built other gamma-ray lenses of various sizes and materials for use in cameras and telescopes, as well as developing optics for Argonne's Advanced Photon Source, which produces the nation's most brilliant X-rays for research.

Media contact: Catherine Foster, 630/252-5580, cfoster@anl.gov
Research contact: Robert Smither, 630-252-4959, rks@aps.anl.gov


Funding: The Advanced Photon Source (APS) is a national synchrotron radiation research facility located at Argonne National Laboratory near Chicago, Illinois. The APS is funded by the U.S. Department of Energy's Office of Science, Office of Basic Energy Sciences.

Argonne National Laboratory, the nation's first national laboratory, conducts basic and applied scientific research across a wide spectrum of disciplines, ranging from high-energy physics to climatology and biotechnology. Since 1990, Argonne has worked with more than 600 companies and numerous federal agencies and other organizations to help advance America's scientific leadership and prepare the nation for the future. Argonne is operated by the University of Chicago as part of the DOE's national laboratory system.

Contents
Search
Comments

previous    next

























"The key is sensitivity and special resolution." —Bob Smither
   previous      next


• Energy Science News • Energy Science News • Energy Science News • Energy Science News •
www.pnl.gov/energyscience/